Cresset Asset Management, LLC Macrogenics Inc Transaction History
Cresset Asset Management, LLC
- $17.3 Billion
- Q4 2024
A detailed history of Cresset Asset Management, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Cresset Asset Management, LLC holds 18,717 shares of MGNX stock, worth $46,043. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,717
Previous 21,320
12.21%
Holding current value
$46,043
Previous $70,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MGNX
# of Institutions
139Shares Held
57MCall Options Held
215KPut Options Held
238K-
Bellevue Group Ag Kuesnacht, V89.93MShares$24.4 Million0.55% of portfolio
-
Armistice Capital, LLC New York, NY6.26MShares$15.4 Million0.34% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$13.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.32MShares$10.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$8.7 Million0.01% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $151M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...